Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Elena A. Schneider"'
Autor:
Elena A. Schneider
In 1762, British forces mobilized more than 230 ships and 26,000 soldiers, sailors, and enslaved Africans to attack Havana, one of the wealthiest and most populous ports in the Americas. They met fierce resistance. Spanish soldiers and local militias
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Highly effective cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator therapies (HEMT), including elexacaftor-tezacaftor-ivacaftor, correct the underlying molecular defect causing CF. HEMT decreases general symptom burden by impr
Externí odkaz:
https://doaj.org/article/9d5f1f1827b146bb8a14d93f4b0da06e
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/89faf3125b6d4090a4195ecbc33024f9
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1488 (2023)
Pulmonary drug delivery has long been used for local and systemic administration of different medications used in acute and chronic respiratory diseases. Certain lung diseases, such as cystic fibrosis, rely heavily on chronic treatments, including ta
Externí odkaz:
https://doaj.org/article/52aed57dcde84230b347c2471e90ec8d
Autor:
Danni Li, Elena K. Schneider-Futschik
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 484 (2023)
Characterized by impaired mucus transport and subsequent enhanced colonization of bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic fibrosis (CF). Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aure
Externí odkaz:
https://doaj.org/article/9f642b39b2904378a981aaee9ae03f97
Publikováno v:
Frontiers in Physiology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/b8ca86ef49cd4deb9191b158c911ea35
Autor:
Patrick O. Hanafin, Isabelle Sermet-Gaudelus, Matthias Griese, Matthias Kappler, Helmut Ellemunter, Carsten Schwarz, John Wilson, Marsha Tan, Tony Velkov, Gauri G. Rao, Elena K. Schneider-Futschik
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: The advent of cystic fibrosis transmembrane conductance regulator protein (CFTR) modulators like ivacaftor have revolutionised the treatment of cystic fibrosis (CF). However, due to the plethora of variances in disease manifestations in C
Externí odkaz:
https://doaj.org/article/0a78f42a14c94d2c9d2a29fe0d706227
Autor:
Maytham Hussein, Xiaohan Hu, Olivia K.A. Paulin, Simon Crawford, Qi Tony Zhou, Mark Baker, Elena K. Schneider-Futschik, Yan Zhu, Jian Li, Tony Velkov
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 18, Iss , Pp 2247-2258 (2020)
The status quo for combating uprising antibacterial resistance is to employ synergistic combinations of antibiotics. Nevertheless, the currently available combination therapies are fast becoming untenable. Combining antibiotics with various FDA-appro
Externí odkaz:
https://doaj.org/article/4860056b8b054c22ac7edcdc1048a934
Publikováno v:
ACS Pharmacology & Translational Science. 6:355-360
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::505d9d672325ca0b2ac3a1eb0b3e3a87
https://doi.org/10.1021/acsptsci.2c00233
https://doi.org/10.1021/acsptsci.2c00233
Autor:
Yan Zhu, Jing Lu, Mei‐Ling Han, Xukai Jiang, Mohammad A. K. Azad, Nitin A. Patil, Yu‐Wei Lin, Jinxin Zhao, Yang Hu, Heidi H. Yu, Ke Chen, John D. Boyce, Rhys A. Dunstan, Trevor Lithgow, Christopher K. Barlow, Weifeng Li, Elena K. Schneider‐Futschik, Jiping Wang, Bin Gong, Bjorn Sommer, Darren J. Creek, Jing Fu, Lushan Wang, Falk Schreiber, Tony Velkov, Jian Li
Publikováno v:
Advanced Science, Vol 7, Iss 15, Pp n/a-n/a (2020)
Abstract Multidrug‐resistant Acinetobacter baumannii is a top‐priority pathogen globally and polymyxins are a last‐line therapy. Polymyxin dependence in A. baumannii (i.e., nonculturable on agar without polymyxins) is a unique and highly‐resi
Externí odkaz:
https://doaj.org/article/92a829d27e4a414f96c5fbfdbdf2014c